128 research outputs found
Nurses\u27 Alumnae Association Bulletin - Volume 5 Number 8
Calling All Nurses
Financial Report
Calendar of Events
Lest You Forget!
Attention
Review of the Alumnae Association Meetings
President\u27s Report
Barton Memorial Division
Oxygen Therapy
Welcome, White Haven Alumnae
Clinical Use of Penicillin in Infections of the Ears, Nose and Throat
Address - Graduation of Nurses, 1945
Miscellaneous Items
The Blood that Kills
The Story of Malaria
Program
Prizes - May, 1946
Capping Exercises
The Economic Security Program of the Pennsylvania State Nurses\u27 Association
The Clara Melville Scholarship Fund
Card of Thanks
The Poet\u27s Corner
The Hospital Pharmacy
Jefferson Medical College Hospital School of Nursing Faculty
Jefferson Hospital Gray Lady Unite, A.R.R.
The Volunteer Nurses\u27 Aides Salute Jefferson Nurses
Changes in the Staff at Jefferson Hospital
Red Cross Recruits
Did You Know That
The Pennsylvania Nurse
Medical College News
Magazine and Newspaper Items
Central Dressing Room and Transfusion Unit
Rules Concerning Central Dressing Room
Radios and Electrical Appliances
Attending College
Nurses in Anesthesia
Condolences
Marriages
New Arrivals
Deaths
The Bulletin Committee
Attention, Alumnae
New Addresse
Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpes
One common method for treating recurrent genital herpes outbreaks is 3–5 day episodic therapy with nucleoside analogues. However, since maximum viral replication occurs within 24 h after the onset of symptoms, short-term patient-initiated episodic therapy started at prodromal onset or at the first appearance of lesions in patients without a prodrome may represent an important option. In a recent randomized trial, single-day famciclovir treatment decreased lesion healing time and the duration of pain and other symptoms by approximately 2 days compared to placebo, and prevented progression to a full outbreak in almost one in four patients. Because single-day treatment is more convenient than traditional therapies, it may lead to improved patient compliance and better overall management of recurrent genital herpes outbreaks
Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: From treatment to prevention
The HIV epidemic continues unabated, with no highly effective vaccine and no cure. Each new infection has significant economic, social and human costs and prevention efforts are now as great a priority as global antiretroviral therapy (ART) scale up. Reverse transcriptase inhibitors, the first licensed class of ART, have been at the forefront of treatment and prevention of mother to child transmission over the past two decades. Now, their use in adult prevention is being
- …